Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study

<p><strong>Background</strong> Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and 14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up campaign in Kilifi County for children aged younger than 5 years. Coverage with at least two...

Full description

Bibliographic Details
Main Authors:	Hammitt, LL, Etyang, AO, Morpeth, SC, Ojal, J, Mutuku, A, Mturi, N, Moisi, JC, Adetifa, IM, Karani, A, Akech, DO, Otiende, M, Bwanaali, T, Wafula, J, Mataza, C, Mumbo, E, Tabu, C, Knoll, MD, Bauni, E, Marsh, K, Williams, TN, Kamau, T, Sharif, SK, Levine, OS, Scott, JAG
Format:	Journal article
Language:	English
Published:	Elsevier 2019

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study

Similar Items